BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9395545)

  • 1. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005.
    Burrows NR; Li Y; Williams DE
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):147-52. PubMed ID: 18334239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of end stage renal disease among low-income blacks and whites.
    Lipworth L; Mumma MT; Cavanaugh KL; Edwards TL; Ikizler TA; Tarone RE; McLaughlin JK; Blot WJ
    PLoS One; 2012; 7(10):e48407. PubMed ID: 23110237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic renal disease: racial and ethnic differences from an epidemiologic perspective.
    Cowie CC
    Transplant Proc; 1993 Aug; 25(4):2426-30. PubMed ID: 8356621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of end-stage renal disease in Georgia.
    McClellan W; Brogan D
    J Med Assoc Ga; 1990 Mar; 79(3):153-6. PubMed ID: 2319217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
    McClellan W; Tuttle E; Issa A
    Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 Feb; 25(2):350-6. PubMed ID: 7847366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
    Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
    Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.